AzTrials
AzTrials

Premature BirthHLPulseSNCT02747069

HeartLight Pulse Study: Evaluation of Heart Rate Using an Electronic Stethoscope and Pre Placed ECG in the Delivery Room

An observational study of Premature Birth, run by University of Nottingham at 1 site in United Kingdom.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

This study will evaluate the accuracy of both an electronic stethoscope and electrocardiogram (ECG) to evaluate heart rate in neonatal patients in the delivery suite. The initial phase of this study will assess the electronic stethoscope use on stable neonates on the neonatal care prior to use in the delivery room. Read more about this study

Who is it for?
Ages Up to 4 months
Conditions the study is for
Premature Birth
What is being tested?
NICU electronic stethoscope and Newborns <32 weeks and ECG
Type of treatment
Medical device
How many people
50 participants
Where
1 siteUnited Kingdom
Study dates
May 2016to Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 4 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Phase 1- neonates of any gestation admitted to NICU with routine ECG and pulse oximetry monitoring

Who may be able to join

  • All must have written informed consent from the participant's mother
  • Phase 1: Any neonate requiring NICU admission and routine monitoring with ECG.
  • Phase 2: Preterm infants ≤32 weeks gestation delivered into a plastic bag/wrap

Who cannot join

  • Phase 1: Infants undergoing comfort care (palliative care). Infants deemed too sick, as assessed by the clinical team caring for them, to tolerate additional procedures. This is unusual but would normally include infants who become more unstable with increased handling
  • Phase 2: Infants >32 weeks gestation Infants where resuscitation is unlikely to be instigated (eg. known lethal condition)

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Nottingham NHS Trust

    Nottingham, NG72UH

Other trials in United Kingdom

About this study

Official title: Determination of Heart Rate in Neonates on the NICU and Delivery Suite Using ECG and Electronic Stethoscope, a Feasibility Study

This study will evaluate the accuracy of both an electronic stethoscope and electrocardiogram (ECG) to evaluate heart rate in neonatal patients in the delivery suite.

The initial phase of this study will assess the electronic stethoscope use on stable neonates on the neonatal care prior to use in the delivery room.

Read the detailed description

Up to 10% of newborns (79K/yr in United Kingdom, 13 million/yr worldwide) require some form of resuscitation at birth. It is estimated that approximately 7 million babies worldwide, especially the premature group, will require more advanced resuscitation. The correct, structured management of the resuscitation in the few 'golden' minutes after birth is critical to prevent significant morbidity (e.g. cerebral palsy due to asphyxiation) or death. There is strong evidence that standardised resuscitation training and algorithms significantly improve newborn outcomes and could reduce mortality by 30% in certain healthcare institution. International newborn resuscitation guidelines state that "a prompt increase in heart rate remains the most sensitive indicator of resuscitation efficacy" and that the stethoscope should be the primary means of assessing heart rate (HR). Provision of an accurate and timely HR value is essential if the best care outcomes are to be achieved. Establishing the HR category allows the resuscitator to decide if the HR is >100 bpm (suggests the baby is well or resuscitation is effective), between 60-100bpm (resuscitation required initially focusing on the airway) or <60bpm (requires much more intensive resuscitation which could include CPR). International guidelines recommend assessing the HR every 30 seconds with a stethoscope to track changes and hence efficacy of resuscitation. However, a number of studies demonstrate that newborn healthcare providers estimate the HR category incorrectly in about 1 in 3 cases, potentially resulting in the incorrect management of the baby. There is now strong evidence linking the need for resuscitation and a poor neurodevelopmental outcome in later childhood. Indeed, a number of large cohort studies have demonstrated that even if a baby requires initial resuscitation, and no further need for on-going care, they are at an increased risk of low intelligence quotient in childhood and are less likely to have paid employment or go to University when adults.

More recently electronic stethoscopes (ES) have been used to determine heart rate variability. Several studies have shown that an ES can reliably evaluate the heart rate in adults, but only one recently published study has demonstrated its use in the neonatal patient. The advantage of using an ES over ECG and pulse oximetry is fast acquisition of HR (<5 sec) and ease of application, both attributes are beneficial in the delivery suite scenario. Furthermore, assessment of HR by auscultation (using a stethoscope) is still the primary technique used in many settings.

ECG, an established and accurate method of monitoring HR, is rarely used in the delivery room for a number of reasons including difficulty ensuring adhesion to the skin (the baby is wet/covered in vernix) and skin damage in premature babies caused by stripping of the electrodes. Current ECG systems also require 3 electrodes to be positioned which can delay resuscitation further. To improve HR assessment at birth we aim to tackle this problem through a variety of means. ECG is not routinely used for delivery room resuscitations mainly due to the impracticalities of attaching the electrodes and setting up the system. Current NICU practice is to place the ECG electrodes onto the baby's chest. It is also possible for the electrodes to be placed on the baby's which is a method commonly adopted on the NICU. Preterm babies are routinely delivered into a plastic bags/wraps to minimise heat loss. By pre-placing the ECG electrodes onto the back of the bag/wrap with small conducting holes in, it should be possible to place the baby onto the bag and connect with the ECG electrodes with a routinely used clinical conducting gel. The baby could be placed onto them and time would be saved by not needing to stick the electrodes on individually and utilising the baby's weight to establish the electrode connections. This would avoid the need to place them individually, which is often time consuming and challenging as they don't still well to wet skin, and avoid skin stripping when removed later.

This study will initially assess the accuracy and reliability of an electronic stethoscopes to evaluate heart rate on stable patients on the neonatal unit compared to routine ECG and pulse oximetry measurements. This will allow comparison of the pre placed ECG system in the second phase of the study.

Conditions
Premature Birth
Being tested
NICU electronic stethoscope, Newborns <32 weeks and ECG
Keywords
Heart rate, Electronic Stethoscope, Electrocardiogram, Resuscitation
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NICU electronic stethoscopeDevice

    Assessment of heart rate using the electronic stethoscope for up to 10 minutes compared to ECG and pulse oximetry devices used to monitor neonates whilst on NICU

  • Newborns <32 weeks and ECGDevice

    The three leads from the ECG device will be pre placed onto a plastic bag prior to delivery. The pre term infant (<32 weeks) placed into the bag at the time of delivery and heart rate will be assessed for up to 30 minutes

Study groups in NCT02747069
Study groupRoleWhat they receive
NICU electronic stethoscopeNeonatal patients of any gestation admitted to the neonatal intensive care unit (NICU) and undergoing routine monitoring with ECG and pulse oximetry Heart rate will be evaluated using an electronic stethoscope
Receives: Device: NICU electronic stethoscope
Newborns <32 weeks and ECGNeonatal patients <32 weeks gestation Heart rate will be assessed at the time of delivery with both an electronic stethoscope and ECG using a pre placed lead system
Receives: Device: NICU electronic stethoscope; Device: Newborns <32 weeks and ECG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate

    Assessment of accuracy (limits of agreement ±10bpm at 2 standard deviations) and reliability (>90% agreement +/- 10 bpm) of an electronic stethoscope to measure heart rate when compared to ECG.

    Measured: 10 minutes

  2. Reliability of Pre placed ECG leads to measure heart rate

    Assess of the reliability of pre-placed ECG to measure heart rate at the time of delivery when compared to heart rate assessed by an electronic stethoscope.

    Measured: 30 minutes

Secondary outcomes (2)
  1. Accuracy of Clinical assessment of heart rate using an electronic stethoscope

    Evaluation of the heart rate by the clinical team when using the electronic stethoscope by subjective counting compared to actual detection of heart rate (computed by software)

    Measured: 30 minutes

  2. Acquisition of video recorded resuscitation of newborns for clinical feedback

    The resuscitation of the neonate in the delivery room will be recorded to allow alignment of data (i.e. time baby placed in bag, time electronic stethoscope used). This video will be used as a resuscitation training tool for training clinicians.

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2016 (estimated)
  2. Study startMay 2016
  3. Primary completionDec 2018 (estimated)
  4. Study completionDec 2018 (estimated)

Why it stopped: New data available in public domain requires re-evaluation of protocol.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02747069
Sponsor's protocol ID
15124
Acronym
HLPulseS
Status last verified
May 2018
First submitted
25 Feb 2016
Last updated
17 May 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Birth, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 17 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate (time frame: 10 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in